LYKALABSNSELyka Labs Limited· PharmaceuticalsHighPositive
Announced Fri, 13 Jun · 13:25 IST

Lyka Labs Limited has informed the Exchange about General Updates

Nclt Scheme FiledStrategic Transactions View source PDF

LYKALABS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Lyka Labs Limited informed the exchanges that the NCLT Ahmedabad Bench hearing on the Scheme of Amalgamation between Lyka Exports Limited (Transferor Company) and Lyka Labs Limited (Transferee Company) was held on June 12, 2025. The case was adjourned and is now listed for further hearing on July 10, 2025. The amalgamation is being processed under Sections 230-232 of the Companies Act, 2013. No swap ratio or financial details were disclosed in this update.

Likely market impact

This is a procedural update with no immediate change for shareholders. The amalgamation remains in progress, and investors should watch the July 10, 2025 hearing for the next substantive update on the scheme's approval.